Literature DB >> 2824488

Transcription from the stromelysin promoter is induced by interleukin-1 and repressed by dexamethasone.

S M Frisch1, H E Ruley.   

Abstract

The stromelysin gene encodes a potent tissue-degrading proteinase whose activity is important in tissue-remoldeling processes such as wound healing, the inflammatory reaction, rheumatoid arthritis, tumor invasion, and possibly embryonic development. In light of the ability of interleukin-1 to amplify, and ability of glucocorticoids to attenuate the inflammatory response, we tested interleukin-1 and dexamethasone for regulatory effects on stromelysin gene expression. We report that interleukin-1 induces the stromelysin gene, and dexamethasone diminishes the level of induction by interleukin-1, epidermal growth factor, phorbol ester, and cAMP elevation (elicited by cholera toxin). Similar responses are conferred upon a chloramphenicol acetyltransferase coding sequence by a 700-base pair stromelysin 5'-flanking fragment, implying transcription regulation by sequence elements in this region.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2824488

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

1.  c-ets1 proto-oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans.

Authors:  N Wernert; M B Raes; P Lassalle; M P Dehouck; B Gosselin; B Vandenbunder; D Stehelin
Journal:  Am J Pathol       Date:  1992-01       Impact factor: 4.307

2.  Downregulation of JE and KC genes by glucocorticoids does not prevent the G0----G1 transition in BALB/3T3 cells.

Authors:  L E Rameh; M C Armelin
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

3.  The glucocorticoid receptor binds to a sequence overlapping the TATA box of the human osteocalcin promoter: a potential mechanism for negative regulation.

Authors:  P E Strömstedt; L Poellinger; J A Gustafsson; J Carlstedt-Duke
Journal:  Mol Cell Biol       Date:  1991-06       Impact factor: 4.272

4.  Repression of the alpha-fetoprotein gene promoter by progesterone and chimeric receptors in the presence of hormones and antihormones.

Authors:  B Turcotte; M E Meyer; M T Bocquel; L Bélanger; P Chambon
Journal:  Mol Cell Biol       Date:  1990-09       Impact factor: 4.272

5.  Effects of curcumin and Ginkgo biloba on matrix metalloproteinases gene expression and other biomarkers of inflammatory bowel disease.

Authors:  Tarek Kamal Motawi; Sherine Maher Rizk; Ahmed Hassan Shehata
Journal:  J Physiol Biochem       Date:  2012-04-26       Impact factor: 4.158

6.  Involvement of the AP-1 site within the 5'-flanking region of the stromelysin-1 gene in induction of the gene expression by UVA irradiation.

Authors:  D Sawamura; T Ohta; K Hanada; H Ishikawa; K Tamai; H Yazima; X Meng; K Nomura; I Hashimoto; A Mauviel; J Uitto
Journal:  Arch Dermatol Res       Date:  1996-09       Impact factor: 3.017

7.  Expression of matrix metalloproteinase-1 and tumor necrosis factor-alpha in ulcerative colitis.

Authors:  Ying-De Wang; Jing-Wei Mao
Journal:  World J Gastroenterol       Date:  2007-11-28       Impact factor: 5.742

8.  Expression of matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) induced by tumour necrosis factor alpha correlates with metastatic ability in a human osteosarcoma cell line.

Authors:  A Kawashima; I Nakanishi; H Tsuchiya; A Roessner; K Obata; Y Okada
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

9.  Heparin inhibits the induction of three matrix metalloproteinases (stromelysin, 92-kD gelatinase, and collagenase) in primate arterial smooth muscle cells.

Authors:  R D Kenagy; S T Nikkari; H G Welgus; A W Clowes
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

10.  Local removal of phagocytic synovial lining cells by clodronate-liposomes decreases cartilage destruction during collagen type II arthritis.

Authors:  P L Van Lent; A E Holthuysen; N Van Rooijen; L B Van De Putte; W B Van Den Berg
Journal:  Ann Rheum Dis       Date:  1998-07       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.